Physician profile
Michael J Lee
NPI 1598969362
$15,732.30
in general payments reported to CMS, 2019-2025
18 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,657 · 2021: $3,766 · 2022: $175 · 2023: $1,648 · 2024: $279 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268 · Travel and Lodging: $844 · Education: $22.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.25 |
| Travel and Lodging | $843.72 |
| Education | $22.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,038.02 | 2019-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $3,662.47 | 2021-2024 | Linx Reflux Management System |
| W. L. Gore & Associates, INC. | $1,532.64 | 2019-2023 | Seamguard, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Ethicon US, LLC | $483.84 | 2019-2024 | Stratafix, Linx Reflux Management System, Harmonic |
| Tela Bio, INC. | $295.80 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $145.09 | 2025 | Daxxify |
| Allergan, INC. | $142.86 | 2021 | |
| Acell, INC. | $120.18 | 2019 | |
| Depuy Synthes Sales INC. | $87.46 | 2019 | |
| Novo Nordisk INC | $57.48 | 2023-2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $50.46 | 2024-2025 | Voquezna |
| Conmed Corporation | $23.84 | 2024 | Airseal |
| Endo Pharmaceuticals INC. | $20.89 | 2019 | |
| Vivus LLC | $17.17 | 2023 | Qsymia |
| Pacira Pharmaceuticals Incorporated | $16.93 | 2024 | Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.53 | 2023 | Contrave |
| Mallinckrodt Enterprises LLC | $11.43 | 2019 | |
| Levita Magnetics International Corp | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.